Search

everythinglearnresearchcommunity

for

Search:↓

The EVInews database provides significantly higher quality information than web-based sources for pharmacists.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Tiny particles called extracellular vesicles show potential for improving skin health in cosmetics, but more research is needed to confirm their safety and effectiveness.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.

Divalproex sodium significantly improved headaches in two-thirds of patients.

A new lipid-based formula using myristyl myristate can improve estradiol treatment for hair loss.

A woman got a scalp condition from using latanoprost, but it improved after stopping the drug and starting other treatments.

Topical tacalcitol ointment can help improve symptoms of EFFC.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Certain gene variations are found in people with polycystic ovary syndrome.

Using Excimer light with topical steroids is the most effective treatment for alopecia areata.

Estazolam reduces anxiety-like behavior in PTSD by increasing allopregnanolone levels.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

A woman developed thick gums from everolimus treatment after a kidney transplant.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

ZD1839 can cause skin issues like acne and hair changes.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Centella asiatica with growth factors improves hair and scalp health.

Topical eflornithine effectively reduces facial hair in women and improves quality of life.

Topical eflornithine effectively reduces unwanted facial hair in women with hirsutism for at least 6 months.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.